Missing/wrong data?
Log in to edit
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study.
scientific article published on 23 January 2017
Author/s
author: Yi-Long Wu, Sergey Orlov, Diego Cortinovis, Chong-Jen Yu, Alexis B Cortot, Denis Moro-Sibilot, Gilberto de Castro, Jean-Charles Soria
Work details
Publication date
January 24, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.